Perspective Therapeutics (CATX) Other Gross PP&E Adjustments (2011 - 2026)

Perspective Therapeutics' Other Gross PP&E Adjustments history runs 16 years deep, the most recent figure standing at $97.4 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments rose 54.69% year-over-year to $97.4 million; the TTM figure through Mar 2026 stood at $97.4 million (up 54.69% YoY), while the FY2025 annual figure was $79.2 million, up 39.91% from the prior year.
• Other Gross PP&E Adjustments came in at $97.4 million for Q1 2026 at Perspective Therapeutics, up from $79.2 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $97.4 million in Q1 2026 to a low of $296000.0 in Q4 2022.
• A 5-year average of $33.8 million and a median of $14.3 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
• Across the five-year window, Other Gross PP&E Adjustments slumped 96.6% in 2022 and jumped 1820.11% in 2024, its largest moves.
• Perspective Therapeutics' Other Gross PP&E Adjustments stood at $296000.0 in 2022, then surged by 896.28% to $2.9 million in 2023, then surged by 1820.11% to $56.6 million in 2024, then surged by 39.91% to $79.2 million in 2025, then climbed by 22.9% to $97.4 million in 2026.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $97.4 million, $79.2 million, and $68.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison